Search research articles
Contact Us
Filters
Showing results (121-130 of 325) with videos related to
Page
of 33
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
September 12, 2025
Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation
Sean D Sullivan, Emma M Cousin, Kevin H Li, et al.
Journal of Pain and Symptom Management
|
August 20, 2018
Depression and Health Care Utilization at End of Life Among Older Adults With Advanced Non-Small-Cell Lung Cancer
Cara L McDermott, Aasthaa Bansal, Scott D Ramsey, et al.
International Journal of Geriatric Psychiatry
|
September 17, 2010
Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models
Balázs Nagy, Alan Brennan, Agnes Brandtmüller, et al.
JAMA
|
December 5, 2023
Reimbursement to Pharmacies for Generic Drugs by Medicare Part D Sponsors
Inmaculada Hernandez, Nico Gabriel, Anna Kaltenboeck, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 18, 2024
Integrating Price Benchmarks and Comparative Clinical Effectiveness to Inform the Medicare Drug Price Negotiation Program
Sean D Sullivan, Olivier J Wouters, Emma M Cousin, et al.
American Journal of Alzheimer'S Disease and Other Dementias
|
March 21, 2013
The validity of dependence as a health outcome measure in Alzheimer's disease
D Eldon Spackman, Srikanth Kadiyala, Peter J Neumann, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
February 26, 2025
Defining a Framework for Sustainable Global Biosimilars Markets Using Findings from a Targeted Literature Review
Joshua A Roth, Victoria W Dayer, Mireia Jofre-Bonet, et al.
Applied Health Economics and Health Policy
|
June 29, 2019
Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA
Lotte Steuten, Vincent Garmo, Hemant Phatak, et al.
Current Alzheimer Research
|
December 20, 2011
Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS
D Eldon Spackman, Srikanth Kadiyala, Peter J Neumann, et al.
Journal of Managed Care & Specialty Pharmacy
|
April 27, 2026
Patient out-of-pocket costs and rheumatology biosimilar competition
Victoria W Dayer, Ryan N Hansen, Joshua Roth, et al.
Page
of 33
Search research articles
Search
Showing results (121-130 of 325) with videos related to
Sort By:
Page
of 33
Journal of Managed Care & Specialty Pharmacy
|
September 12, 2025
Selected drugs, therapeutic alternatives, and price benchmarks for IPAY 2027 Medicare drug price negotiation
Sean D Sullivan, Emma M Cousin, Kevin H Li, et al.
Journal of Pain and Symptom Management
|
August 20, 2018
Depression and Health Care Utilization at End of Life Among Older Adults With Advanced Non-Small-Cell Lung Cancer
Cara L McDermott, Aasthaa Bansal, Scott D Ramsey, et al.
International Journal of Geriatric Psychiatry
|
September 17, 2010
Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models
Balázs Nagy, Alan Brennan, Agnes Brandtmüller, et al.
JAMA
|
December 5, 2023
Reimbursement to Pharmacies for Generic Drugs by Medicare Part D Sponsors
Inmaculada Hernandez, Nico Gabriel, Anna Kaltenboeck, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 18, 2024
Integrating Price Benchmarks and Comparative Clinical Effectiveness to Inform the Medicare Drug Price Negotiation Program
Sean D Sullivan, Olivier J Wouters, Emma M Cousin, et al.
American Journal of Alzheimer'S Disease and Other Dementias
|
March 21, 2013
The validity of dependence as a health outcome measure in Alzheimer's disease
D Eldon Spackman, Srikanth Kadiyala, Peter J Neumann, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
February 26, 2025
Defining a Framework for Sustainable Global Biosimilars Markets Using Findings from a Targeted Literature Review
Joshua A Roth, Victoria W Dayer, Mireia Jofre-Bonet, et al.
Applied Health Economics and Health Policy
|
June 29, 2019
Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA
Lotte Steuten, Vincent Garmo, Hemant Phatak, et al.
Current Alzheimer Research
|
December 20, 2011
Measuring Alzheimer disease progression with transition probabilities: estimates from NACC-UDS
D Eldon Spackman, Srikanth Kadiyala, Peter J Neumann, et al.
Journal of Managed Care & Specialty Pharmacy
|
April 27, 2026
Patient out-of-pocket costs and rheumatology biosimilar competition
Victoria W Dayer, Ryan N Hansen, Joshua Roth, et al.
Page
of 33